International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15
Authors:
- on behalf of the EORTC QoL GroupOGon behalf of the EORTC QoL Group
- Marianne J. HjermstadMHMarianne J. Hjermstad
- Mia BergenmarMBMia Bergenmar
- Kristin BjordalKBKristin Bjordal
- Monica PintoMPMonica Pinto
- Iwona M. TomaszewskaITIwona M. Tomaszewska
- 25 April 2016
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 24 (9) , 3915-3924
Abstract
Purpose This international EORTC validation study (phase IV) is aimed at testing the psychometric properties of a quality of life (QoL) module related to oral health problems in cancer patients. Methods The phase III module comprised 17 items with four hypothesized multi-item scales and three single items. In phase IV, patients with mixed cancers, in different treatment phases from 10 countries completed the EORTC QLQ-C30, the QLQ-OH module, and a debriefing interview. The hypothesized structure was tested using combinations of classical test theory and item response theory, following EORTC guidelines. Test–retest assessments and responsiveness to change analysis (RCA) were performed after 2 weeks. Results Five hundred seventy-two patients (median age 60.3, 54 % females) were analyzed. Completion took sticky saliva/mouth soreness/sensitivity to food/drink). Face and convergent validity and internal consistency were confirmed. Test–retest reliability (n = 60) was demonstrated as was RCA for patients undergoing chemotherapy (n = 117; p = 0.06). The resulting QLQ-OH15 discriminated between clinically distinct patient groups, e.g., low performance status vs. higher (p < 000.1), and head-and-neck cancer versus other cancers (p < 0.03). Conclusion The EORTC module QLQ-OH15 is a short, well-accepted assessment tool focusing on oral problems and QoL to improve clinical management. Trial Registration ClinicalTrials.gov Identifier: NCT01724333.Keywords
Funding Information
- EORTC Quality of Life Group (QLG) group; . (Grant no. 001/2012)
This publication has 29 references indexed in Scilit:
- The EORTC QLQ-OH17: A supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patientsEuropean Journal of Cancer, 2012
- The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double‐blind, placebo‐controlled, randomized, phase III clinical trialJournal of Oral Pathology & Medicine, 2011
- A systematic review of oral fungal infections in patients receiving cancer therapySupportive Care in Cancer, 2010
- A systematic review of dental disease in patients undergoing cancer therapySupportive Care in Cancer, 2010
- A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impactSupportive Care in Cancer, 2010
- A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of lifeSupportive Care in Cancer, 2010
- Indications for and Referrals to Oral Care for Cancer Patients in a County HospitalActa Oncologica, 1996
- Development of a European Organization for Research and Treatment of Cancer (Eortc) Questionnaire Module to be Used in Quality of Life Assessments in Head and Neck Cancer PatientsActa Oncologica, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948